Filter by:
HTAi Webinar | HTA Informing Innovative Drugs’ Market Access in LMICs
The WHO identifies achieving Universal Health Coverage (UHC) as a strategic priority, encompassing a full range of essential health services, of which technology constitutes a…
Read Moreabout HTAi Webinar | HTA Informing Innovative Drugs’ Market Access in LMICs
HTAi Webinar | A Framework for Characterizing Impact of Patient Involvement in HTA
HTAi’s Patient and Citizen Involvement in HTA Interest Group (PCIG) proposes a framework for reporting on the impact of patient involvement in HTA. A common…
Read Moreabout HTAi Webinar | A Framework for Characterizing Impact of Patient Involvement in HTA
HTAi Webinar | How Patient Involvement is Making a Difference in HTA – Perspectives of Impact
For more information about HTAi, visit our website: https://www.htai.org
Read Moreabout HTAi Webinar | How Patient Involvement is Making a Difference in HTA – Perspectives of Impact
HTAi Webinar | Do Patient Preferences Influence HTA Decisions?
The HTAi PCIG Patient Preference Sub-Committee has initiated a project designed to improve the likelihood that patient preferences can and will be used more frequently…
Read Moreabout HTAi Webinar | Do Patient Preferences Influence HTA Decisions?
HTAi 2022 Annual Meeting – Keynote
Keynote address by Prof. Marcel Levi Prof. Marcel Levi is an Internist and, since April 2021, the Chairman of the Netherlands Organization for Scientific Research…
Read Moreabout HTAi 2022 Annual Meeting – Keynote
HTAi 2022 Annual Meeting: Special Session – HTA in Challenging Times: Experience in Ukraine
Read Moreabout HTAi 2022 Annual Meeting: Special Session – HTA in Challenging Times: Experience in UkraineHTAi 2021 Annual Meeting – Keynote 3
Innovating Health Technology Assessment to Support Novel Interventions Dr Melanie Lee, CEO, LifeARC LifeArc’s CEO Dr Melanie Lee, PhD, CBE. Prior to joining LifeArc Melanie…
Read Moreabout HTAi 2021 Annual Meeting – Keynote 3
HTAi 2021 Annual Meeting – Keynote 1
Driving Innovation: the Regulator-HTA Partnership Dr June Raine CBE, Chief Executive, Medicines and Healthcare Products Regulatory Agency, UK Dr Raine trained in general medicine in…
Read Moreabout HTAi 2021 Annual Meeting – Keynote 1
HTAi 2021 Annual Meeting Keynote 2 – A Tale of Two Pandemics:
A tale of two pandemics: Neil Bertelsen, a HIV patient advocate reflects on the lessons learned from the HIV pandemic and asks why we are…
Read Moreabout HTAi 2021 Annual Meeting Keynote 2 – A Tale of Two Pandemics:
HTAi 2018 Annual Meeting – Key Note
Ms. Hannah Kettler Senior Program Office, Bill & Melinda Gates Foundation, USA Hannah Kettler, Ph.D., is a Senior Program Officer on the Life Sciences Partnerships…
Read Moreabout HTAi 2018 Annual Meeting – Key Note
HTAi 2022 Annual Meeting – Keynote
Keynote address by Prof. Marcel Levi Prof. Marcel Levi is an Internist and, since April 2021, the Chairman of the Netherlands Organization for Scientific Research…
Read Moreabout HTAi 2022 Annual Meeting – Keynote
HTAi Webinar: The Characteristics of Rare Diseases That Complicate the Assessment of Technology Value
This HTAi Webinar is hosted by the HTAi Rare Diseases Interest Group. Evaluating the value of rare disease technologies poses challenges due to factors like…
Read Moreabout HTAi Webinar: The Characteristics of Rare Diseases That Complicate the Assessment of Technology Value